Abstract:Objective This study aimed to investigate the influence of exposure to ambient fine particulate matter (PM 2.5 ) and its components during pregnancy on the prevalence of preterm birth (PTB). Additionally, we sought to identify the susceptible exposure window. Furthermore, we explored the potential mediating role of blood analysis and a comprehensive metabolic panel in the association between pollutant exposure and PTB incidence. Methods This birth cohort study recruited 139 participants with PTB outcomes and 1713 controls from Fujian Maternal and Child Health Hospital between January 2021 and June 2023. Sociodemographic characteristics and clinical treatment data during participants' first pregnancies were collected. The exposure levels to pollutants during pregnancy were estimated via a combined geographic–statistical model utilising satellite remote sensing data. The distributional lag nonlinear modelling was employed to assess associations between pollutant exposure during pregnancy and the prevalence of PTB. Weighted quantile regression was used to identify key components associated with PM 2.5 and PTB during pregnancy. Additionally, a mediating effect analysis was conducted to evaluate the role of blood analysis. The metabolic profile was used to screen for differentially abundant metabolites associated with PTB and explore their relative expression in relation to air pollutants and PTB incidence. Results Following the adjustment for potential confounding variables, the mean weekly susceptibility windows for PM 2.5 were identified as 7–10, 16–19, and 22–28 weeks; 8–10, and 15–19 weeks for inorganic sulfate; 6–10, and 15–28 weeks for nitrate; 6–12, and 15–28 weeks for ammonium (NH 4 + ); and 7–9, 18–20, and 22–36 weeks for organic matter. During mixed exposure to PM 2.5 components, the key component is NH 4 + . In the mixed exposure to PM 2.5 components, NH 4 + emerged as a key contributor. The results of the mediation analysis revealed that haemoglobin played a mediating role, accounting for 21.53 % of the association between exposure to environmental pollutants and the prevalence of PTB. It is noteworthy that, no mediating effects were observed for the other variables. Furthermore, non-targeted metabolomics identified 17 metabolites associated with PTB. Among these factors, hydrogen phosphate may impact metabolic pathways such as oxidative phosphorylation, influencing the risk of PTB. The interplay between environmental pollutants and metabolites, particularly through oxidative phosphorylation pathways, may contribute to PTB incidence. Conclusions The evidence indicates that exposure to PM 2.5 and its components during pregnancy were a significant risk factor for PTB. Notably, specific weekly exposure windows were identified for pollutants during pregnancy. Among the PM 2.5 components, NH 4 + exhibited the most substantial weight in the association analysis between exposure to the mixture of components and PTB. Furthermore, our mediation analysis revealed that haemoglobin serves as a partial mediator in the relationship between exposure to pollutants during pregnancy and the prevalence of PTB. Additionally, maternal serum metabolic profiles differed between the preterm and control groups. Notably, a combined effect involving hydrogen phosphate and mixed exposure to PM 2.5 fractions further contributed to the development of PTB. Oxidative phosphorylation pathways may play pivotal roles in this intricate association.

Associations between urinary hydroxylated polycyclic aromatic hydrocarbon biomarker concentrations and measures of timing of delivery and infant size at birth

Urinary Biomarkers of Polycyclic Aromatic Hydrocarbons and Timing of Pubertal Development: The California PAH Study

Urinary polycyclic aromatic hydrocarbon metabolites and their association with oxidative stress among pregnant women in Los Angeles

Association of Prenatal Exposure to PAHs with Anti-Müllerian Hormone (AMH) Levels and Birth Outcomes of Newborns.

Urinary polycyclic aromatic hydrocarbon metabolites in Chinese pregnant women: Concentrations, variability, predictors, and association with oxidative stress biomarkers

Association Between Elevated Placental Polycyclic Aromatic Hydrocarbons (pahs) and PAH-DNA Adducts from Superfund Sites in Harris County, and Increased Risk of Preterm Birth (PTB).

Effects of Prenatal Polycyclic Aromatic Hydrocarbon Exposure on Neonatal Outcomes—MLR and BKMR Models

An evaluation of in utero polycyclic aromatic hydrocarbon exposure on the neonatal meconium microbiome

[Association of Phthalate and Polycyclic Aromatic Hydrocarbon Exposure During Early Pregnancy with Premature Delivery: A Cohort Study].

Urinary concentrations of phthalate metabolites in relation to preeclampsia and other hypertensive disorders of pregnancy in the environmental influences on child health outcomes (ECHO) program

Maternal Estradiol Mediates the Effects of Polycyclic Aromatic Hydrocarbons and Phthalates on Neonatal Birth Outcomes

A summary of recent findings on birth outcomes and developmental effects of prenatal ETS, PAH, and pesticide exposures

Maternal exposure to polycyclic aromatic hydrocarbons during pregnancy and timing of pubertal onset in a longitudinal mother-child cohort in rural Bangladesh

Prenatal Exposure to Polycyclic Aromatic Hydrocarbons and Birth Weight in China

Gestational Hormone Concentrations Are Associated With Timing of Delivery in a Fetal Sex-Dependent Manner

Prenatal exposure to polycyclic aromatic hydrocarbons and growth parameters

Associations of urinary non-persistent endocrine disrupting chemical biomarkers with early-to-mid pregnancy plasma sex-steroid and thyroid hormones

Prenatal polycyclic aromatic hydrocarbon exposure and neurodevelopment among children in Puerto Rico

Association Between Prenatal Phthalate Exposure and Birth Outcomes

Prenatal Urinary Polycyclic Aromatic Hydrocarbon Metabolites, Global DNA Methylation in Cord Blood, and Birth Outcomes: A Cohort Study in China.

Associations of air pollutants and related metabolites with preterm birth during pregnancy